Nuo Therapeutics, Inc. Employee Directory
Biotechnology ResearchTexas, United States11-50 Employees
Nuo Therapeutics, Inc. is a biotechnology company based in Houston, Texas, focused on developing and commercializing individualized wound care therapies that leverage a patient’s innate regenerative abilities to promote healing. Its flagship product, Aurix, is a biodynamic hematogel derived from a patient’s own platelets and plasma, used at the point of care to stimulate healing in chronic wounds such as diabetic foot ulcers, venous leg ulcers, and pressure injuries. The approach emphasizes autologous materials to engage the body’s natural repair processes at the wound site. The company’s customers are clinicians and healthcare providers who treat chronic wounds, seeking therapies that may improve healing outcomes by utilizing the patient’s biology. A notable recent development is an exclusive private label distribution agreement with Smith+Nephew to market the CENTRIO PRP System in the United States. This move places Nuo within the commercial-stage biotechnology and medical device space and reflects a strategy to expand access through partnerships.